BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Dose Control LLC's Patented Tamper-Resistant Programmable Portable Pill Dispenser Awarded KSEF Phase 0 Grant


7/29/2009 2:26:54 PM

Kentucky-based startup firm Dose Control LLC announces award of Kentucky Science & Engineering Foundation phase 0 grant to utilize toward SBIR grant application. Dose Control LLC is the assignee of US patent 7,108,153 and information, including functionality demo video's, can be seen at www.dosecontrol-llc.com. The patent covers a unique intelligent pill/capsule/tablet dispenser.

It is robust and simplistic in design, to enable a low retail price point. Yet it is tamper-resistant, programmable, portable, refillable and is designed to dispense medication no faster than the prescribed and programmed rate. It is an alternative to “pop top, access all at once” pill containers for a portion of the millions of annual US narcotic painkiller prescriptions.

The primary purpose of the dispenser is to deter prescription drug abuse, which continue to reach alarming levels. However, various patient alerts (audio/visual/vibrating) could be incorporated into the device using the primary patent embodiments, to also increase medication adherence. We envision two distinct markets for the patented dispenser, be the intended patient targets prescription drug abuse deterrence or medication adherence, or an overlap of the two patient targets: Consumer direct purchase.

Consumers would receive their prescription pills from the pharmacy in standard “pop top, access all at once” container, then fill and refill the Dose Control dispenser’s cartridge cavities, push the countdown timer to prescribed dosage rate, and lock the device with self-lock feature, for use by their family, friends, or those they care for. Pharmacy-filled. Pharmacists would fill and refill the Dose Control dispenser’s cartridge with blister packs created at the manufacturer or pharmacy level, push the countdown timer to prescribed dosage rate, lock the device with self-lock feature, then provide to patient. Each device could be serial numbered and tracked by patient, and if patient could not provide their originally issued dispenser to pharmacist, refills could be ceased until patient consults with physician or pharmacist. Both embodiments summarized above are described in the patent.

Dose Control LLC is currently seeking strategic partners to accelerate the introduction of the patented dispenser into the market.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES